News and Press Releases
Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Use in Preclinical and Clinical Drug Development
Range of Highly Selective Anti-Idiotypic Antibodies Now Includes Six Antibodies Specific to Dupilumab and its Biosimilars for Bioanalysis and Drug Monitoring 5 October 2023 -- California, US -- Bio-Rad Laboratories,...
Category: Drug Discovery
Posted: October 5, 2023
Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET
Additional Analytical Laboratory and Spray Drying Investments
5 October 2023 -- New Jersey, US -- Experic, a contract development and manufacturing organisation (CDMO) and clinical supply services company serving the biopharmaceutical industry, announced today the successful completion of...
Category: Manufacturing and Packing
Posted: October 5, 2023
Gens & Associates launches latest World Class RIM study – the largest yet – to define & hone “industry standard” practice
Stakeholders across the global Life Sciences industry & regulatory provider community are invited to play their part in cementing the ultimate approach to regulatory information management 4 October 2023 --...
Category: Other
Posted: October 5, 2023
TekniPlex Hires Rahul Goturi as Chief Information Officer
Executive-level move coincides with retirement of longtime CIO Jeff Rishel Goturi brings more than 15 years of CIO experience at global organisations 4 October 2023 -- Ohio, US -- TekniPlex,...
Category: Manufacturing and Packing
Posted: October 4, 2023
Industrielaan 37 B-9320 Erembodegem Belgium Tel: +32 (0)53 650711 VAT 0425.537.515
FUJIFILM Diosynth Biotechnologies President and CEO Lars Petersen appoints Maja Pedersen as Chief Quality Officer
4 October 2023 -- Hillerød, Denmark -- FUJIFILM Diosynth Biotechnologies president and CEO Lars Petersen today announced a new strategic leadership appointment to support the company through its next growth...
Category: Biotechnology
Posted: October 4, 2023
Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company’s Combination Vaccine Against Influenza and COVID-19
mRNA-1083 showed strong immunogenicity against influenza and COVID-19, with an acceptable reactogenicity and safety profile, compared to licensed standalone vaccines Company to begin phase 3 trial of mRNA-1083 in adults...
Category: Clinical Trials, Drug Discovery
Posted: October 4, 2023
Evonetix places first DNA synthesis development platform at Imperial College London
External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialisation 4 October 2023 -- Cambridge, UK -- EVONETIX,...
Category: Drug Discovery
Posted: October 4, 2023
Vertex Presents Positive, Updated VX-880 Results From Ongoing phase 1/2 Study in Type 1 Diabetes at the European Association for the Study of Diabetes 59th Annual Meeting
All patients treated with VX-880 in Parts A and B have follow-up data beyond Day 90 and have demonstrated islet cell engraftment and glucose-responsive insulin production All patients showed improvement...
Category: Clinical Trials
Posted: October 4, 2023
Ubiquigent collaborates with Imperial College London on DUB probe discovery to facilitate preclinical and clinical target engagement studies
Sponsored PhD student will join Professor Ed Tate’s group at Imperial College London, UK, in the EPSRC Centre for Doctoral Training in Chemical Biology Project aims to develop the next...
Category: Biotechnology, Drug Discovery
Posted: October 4, 2023
University Incubator Dundee Technopole James Lindsay Place Dundee DD1 5JJ Scotland, UK
Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialisation
Appointment of Vincent Smith PhD, as chief technology officer and Jessica Rich as VP of Business Development Follows Broken String’s successful $15m Series A fundraising round in September 2023 Will...
Category: Biotechnology
Posted: October 4, 2023
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR
DSM-FIRMENICH TO DEBUT AT CPHI, SHARING ITS VISION FOR PURPOSE-POWERED SOLUTIONS FOR THE PHARMACEUTICAL INDUSTRY
3 October 2023 – Kaiseraugst, Switzerland – Following the merger of two iconic companies – DSM and Firmenich – in May 2023, dsm-firmenich will make its debut at CPHI Barcelona...
Category: BioManufacturing, Pharmaceutical
Posted: October 4, 2023
Sphere Fluidics’ Cyto-Mine system selected by FairJourney Biologics to advance cell line development workflows
Investment to expand cell line development capabilities and accelerate customer workflows, as part of its diverse and tailored antibody solutions 3 October 2023 – Cambridge, UK, and Porto, Portugal –...
Category: BioManufacturing, Biotechnology, Drug Delivery, Drug Discovery, Pharmaceutical
Posted: October 4, 2023
The Jonas Webb Building, Babraham Research Campus, Babraham, Cambridge CB22 3AT, United Kingdom
DIOSynVax and Ethris Publish Preclinical Proof of Concept for Their Broadly Protective Vaccine Technologies in Nature Biomedical Engineering
Successful vaccine candidate combining DIOSynVax's computational multi-virus vaccine antigen payload technology and Ethris’ proprietary non-immunogenic messenger RNA (SNIM mRNA) and lipidoid nanoparticle (SNaP LNP) platforms Data demonstrates broad in vivo...
Category: BioManufacturing, Biotechnology
Posted: October 4, 2023
Signant Health Launches Signant Biotech to Accelerate and Streamline Clinical Development for Emerging Biopharmaceutical Organisations
3 October 2023 -- Philadelphia, US -- Signant Health, the leader in evidence generation for modern clinical trials, announced today the launch of Signant Biotech – an integrated clinical research...
Category: Clinical Trials
Posted: October 4, 2023
Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
21 September 2023 – Dublin, Ireland – PRNewswire ‒ Jazz Pharmaceuticals today announced that the European Commission (EC) has granted marketing authorization for Enrylaze (JZP458; a recombinant Erwinia asparaginase or...
Category:
Posted: October 3, 2023
Waterloo Exchange, Waterloo Road, Dublin 4
